antimony has been researched along with Acute Promyelocytic Leukemia in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Bizzi, CA; Davidson, CB; DE Almeida, LY; Fontanari Krause, LM; Krause, A; Mortari, SR; Rego, EM; Salles, B; Viana, AR | 1 |
Bu, N; Chen, YJ; Hao, R; Hussain, L; Lan, YF; Lu, XY; Ma, LY; Maimaitiyiming, Y; Naranmandura, H; Wang, C; Wang, QQ; Yang, C | 1 |
Dejean, A; Miller, WH; Müller, S | 1 |
Garnier-Suillerot, A; Petroutsa, M; Salerno, M | 1 |
4 other study(ies) available for antimony and Acute Promyelocytic Leukemia
Article | Year |
---|---|
Activity of Free and Liposomal Antimony Trioxide in the Acute Promyelocytic Leukemia Cell Line NB4.
Topics: Antimony; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Carriers; Humans; Leukemia, Promyelocytic, Acute; Liposomes; Nanoparticle Drug Delivery System; Reactive Oxygen Species | 2021 |
Integrity of zinc finger motifs in PML protein is necessary for inducing its degradation by antimony.
Topics: Antimony; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Humans; Leukemia, Promyelocytic, Acute; Oncogene Proteins, Fusion; Promyelocytic Leukemia Protein; Proteolysis; Zinc Fingers | 2019 |
Trivalent antimonials induce degradation of the PML-RAR oncoprotein and reorganization of the promyelocytic leukemia nuclear bodies in acute promyelocytic leukemia NB4 cells.
Topics: Antimony; Cell Nucleus; Humans; Leukemia, Promyelocytic, Acute; Neoplasm Proteins; Oncogene Proteins, Fusion; Tumor Cells, Cultured | 1998 |
The MRP1-mediated effluxes of arsenic and antimony do not require arsenic-glutathione and antimony-glutathione complex formation.
Topics: Antimony; Antimony Potassium Tartrate; Arsenic; Arsenic Trioxide; Arsenicals; Biological Transport, Active; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Glutathione; Humans; K562 Cells; Kinetics; Leukemia, Promyelocytic, Acute; Multidrug Resistance-Associated Proteins; Oxides; Spectrophotometry, Atomic; Tumor Cells, Cultured | 2002 |